APR 17, 2021 12:10 PM PDT

Psychosis from Cannabis Use Linked to Genes for Schizophrenia

WRITTEN BY: Annie Lennon

For some time now, cannabis users have been known to be at risk of developing psychosis more often than nonusers. Now though, researchers from King’s College London have found that cannabis users with a genetic predisposition to schizophrenia are especially at risk.

For the study, the researchers analyzed data from the UK Biobank, a biomedical database containing in-depth information about participants’ health and genomes. In particular, the researchers examined the relationship between genetics, cannabis use, and psychotic experiences from 109,308 people. 

To do so, they looked at reports of how frequently patients used cannabis and whether they had any psychotic experiences, characterized as auditory or visual hallucinations. The researchers also scored each participant’s genetic risk for schizophrenia by looking at which of their DNA mutations were more common among those with schizophrenia than the general population. 

In the end, they found that people who used cannabis were 50% more likely than nonusers to report psychotic experiences. The incidence of these experiences, however, was 60% for those with the highest genetic risk scores for schizophrenia and 40% for those with the lowest genetic risk sores.   

The researchers say that their results are the first evidence that people genetically prone to psychosis may be disproportionately affected by cannabis. They added that as genetic risk scoring is still in early development, genetics may have an even more significant influence on the relationship between cannabis and psychosis than currently known. 

“This study, while limited in scope, is an important step forward in understanding how cannabis use and genetics may interact to influence psychosis risk,” says Dr. Shreejoy Tripathy, senior author of the study.

“The more we know about the connection between cannabis and psychosis, the more we can inform the public about the potential risks of using this substance. This research offers a window into a future where genetics can help empower individuals to make more informed decisions about drug use.”

 

Sources: Neuroscience NewsNature

About the Author
  • Science writer with a keen interest in behavioral biology, consciousness medicine and technology. Her current focus is how the interplay of these fields can create meaningful interactions, products and environments.
You May Also Like
JAN 13, 2021
Cannabis Sciences
Cannabis and Tobacco Smoke Contain Same Toxins
JAN 13, 2021
Cannabis and Tobacco Smoke Contain Same Toxins
Cannabis and tobacco smoke are known to share some of the same toxins. Now, researchers from Dana-Farber Cancer Institut ...
FEB 24, 2021
Health & Medicine
CBG and CBD Cannabinoids Show Worth in Thwarting Glioblastoma Tumors
FEB 24, 2021
CBG and CBD Cannabinoids Show Worth in Thwarting Glioblastoma Tumors
With the average length of survival following diagnosis being only 16 months, a glioblastoma — malignant tumor aff ...
APR 10, 2021
Cannabis Sciences
Cannabis Users Exercise More than Nonusers
APR 10, 2021
Cannabis Users Exercise More than Nonusers
The rate of cannabis use among American adults tripled between 2003 and 2018 from 4.1% to 15.9%. During this time, some ...
APR 20, 2021
Health & Medicine
Cannabis Users Tend to Exercise More
APR 20, 2021
Cannabis Users Tend to Exercise More
Two recent studies have shown that far from performing less exercise, people who use marijuana are actually more active. ...
APR 22, 2021
Cannabis Sciences
Cannabis Use Disorder in Pregnancy Linked to Infant Health Problems
APR 22, 2021
Cannabis Use Disorder in Pregnancy Linked to Infant Health Problems
Researchers have found that babies born to mothers diagnosed with cannabis use disorders at delivery are more likely to ...
MAY 02, 2021
Cannabis Sciences
Medical Cannabis for Epilepsy May Be Linked to Early Puberty
MAY 02, 2021
Medical Cannabis for Epilepsy May Be Linked to Early Puberty
Current research suggests that cannabidiol (CBD) oil may be effective in managing seizures in childhood-onset epilepsy. ...
Loading Comments...